QQQ   389.81 (-0.10%)
AAPL   189.37 (-0.54%)
MSFT   378.85 (-1.01%)
META   332.20 (-2.00%)
GOOGL   134.99 (-1.61%)
AMZN   146.32 (-0.48%)
TSLA   244.14 (-1.05%)
NVDA   481.40 (+0.67%)
NIO   7.18 (-0.55%)
BABA   74.68 (-2.68%)
AMD   123.85 (+1.51%)
T   16.30 (+0.74%)
F   10.59 (+2.12%)
MU   76.69 (+0.75%)
CGC   0.56 (+3.71%)
GE   118.86 (+0.01%)
DIS   92.50 (+0.00%)
AMC   7.17 (+6.86%)
PFE   30.08 (+1.31%)
PYPL   57.97 (-0.86%)
XOM   102.34 (-1.50%)
QQQ   389.81 (-0.10%)
AAPL   189.37 (-0.54%)
MSFT   378.85 (-1.01%)
META   332.20 (-2.00%)
GOOGL   134.99 (-1.61%)
AMZN   146.32 (-0.48%)
TSLA   244.14 (-1.05%)
NVDA   481.40 (+0.67%)
NIO   7.18 (-0.55%)
BABA   74.68 (-2.68%)
AMD   123.85 (+1.51%)
T   16.30 (+0.74%)
F   10.59 (+2.12%)
MU   76.69 (+0.75%)
CGC   0.56 (+3.71%)
GE   118.86 (+0.01%)
DIS   92.50 (+0.00%)
AMC   7.17 (+6.86%)
PFE   30.08 (+1.31%)
PYPL   57.97 (-0.86%)
XOM   102.34 (-1.50%)
QQQ   389.81 (-0.10%)
AAPL   189.37 (-0.54%)
MSFT   378.85 (-1.01%)
META   332.20 (-2.00%)
GOOGL   134.99 (-1.61%)
AMZN   146.32 (-0.48%)
TSLA   244.14 (-1.05%)
NVDA   481.40 (+0.67%)
NIO   7.18 (-0.55%)
BABA   74.68 (-2.68%)
AMD   123.85 (+1.51%)
T   16.30 (+0.74%)
F   10.59 (+2.12%)
MU   76.69 (+0.75%)
CGC   0.56 (+3.71%)
GE   118.86 (+0.01%)
DIS   92.50 (+0.00%)
AMC   7.17 (+6.86%)
PFE   30.08 (+1.31%)
PYPL   57.97 (-0.86%)
XOM   102.34 (-1.50%)
QQQ   389.81 (-0.10%)
AAPL   189.37 (-0.54%)
MSFT   378.85 (-1.01%)
META   332.20 (-2.00%)
GOOGL   134.99 (-1.61%)
AMZN   146.32 (-0.48%)
TSLA   244.14 (-1.05%)
NVDA   481.40 (+0.67%)
NIO   7.18 (-0.55%)
BABA   74.68 (-2.68%)
AMD   123.85 (+1.51%)
T   16.30 (+0.74%)
F   10.59 (+2.12%)
MU   76.69 (+0.75%)
CGC   0.56 (+3.71%)
GE   118.86 (+0.01%)
DIS   92.50 (+0.00%)
AMC   7.17 (+6.86%)
PFE   30.08 (+1.31%)
PYPL   57.97 (-0.86%)
XOM   102.34 (-1.50%)

Regency Centers Stock Price, News & Analysis (NASDAQ:REG)

$61.47
-0.38 (-0.61%)
(As of 11/29/2023 ET)
Compare
Today's Range
$61.37
$62.86
50-Day Range
$56.99
$62.74
52-Week Range
$54.72
$68.56
Volume
856,579 shs
Average Volume
950,900 shs
Market Capitalization
$11.35 billion
P/E Ratio
28.86
Dividend Yield
4.23%
Price Target
$71.14

Regency Centers MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
15.7% Upside
$71.14 Price Target
Short Interest
Healthy
1.46% of Shares Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.05
Upright™ Environmental Score
News Sentiment
0.43mentions of Regency Centers in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
1.69%
From $4.15 to $4.22 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.49 out of 5 stars

Finance Sector

249th out of 841 stocks

Real Estate Investment Trusts Industry

45th out of 176 stocks


REG stock logo

About Regency Centers Stock (NASDAQ:REG)

Regency Centers is a preeminent national owner, operator, and developer of shopping centers located in suburban trade areas with compelling demographics. Our portfolio includes thriving properties merchandised with highly productive grocers, restaurants, service providers, and best-in-class retailers that connect to their neighborhoods, communities, and customers. Operating as a fully integrated real estate company, Regency Centers is a qualified real estate investment trust (REIT) that is self-administered, self-managed, and an S&P 500 Index member.

REG Stock Price History

REG Stock News Headlines

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Q3 2023 Regency Centers Corp Earnings Call
Regency Centers sees strong Q3 performance
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Regency Centers raises dividend by 3.1%
Regency Centers FFO of $1.02 in-line
Regency Centers Reports Q3 Results
Regency Centers Reports Third Quarter 2023 Results
Regency Centers Q3 2023 Earnings Preview
Macerich (MAC) Q3 FFO Meet Estimates
Regency Centers Corp Preferred Series A (REGCP)
Argus Research Upgrades Regency Centers (REG)
See More Headlines
Receive REG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Regency Centers and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/04/2023
Ex-Dividend for 10/4 Dividend
9/13/2023
Dividend Payable
10/04/2023
Today
11/29/2023
Ex-Dividend for 1/3 Dividend
12/13/2023
Fiscal Year End
12/31/2023
Dividend Payable
1/03/2024
Next Earnings (Estimated)
2/08/2024

Industry, Sector and Symbol

Industry
Real estate investment trusts
Sub-Industry
N/A
Sector
Finance
Current Symbol
NASDAQ:REG
Employees
440
Year Founded
1963

Price Target and Rating

Average Stock Price Target
$71.14
High Stock Price Target
$74.00
Low Stock Price Target
$69.00
Potential Upside/Downside
+15.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
6 Analysts

Profitability

Net Income
$482.86 million
Pretax Margin
33.89%

Debt

Sales & Book Value

Annual Sales
$1.22 billion
Cash Flow
$4.58 per share
Book Value
$37.96 per share

Miscellaneous

Free Float
182,735,000
Market Cap
$11.35 billion
Optionable
Optionable
Beta
1.19

Social Links

Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report














REG Stock Analysis - Frequently Asked Questions

Should I buy or sell Regency Centers stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Regency Centers in the last twelve months. There are currently 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" REG shares.
View REG analyst ratings
or view top-rated stocks.

What is Regency Centers' stock price target for 2024?

6 Wall Street research analysts have issued 12 month price objectives for Regency Centers' shares. Their REG share price targets range from $69.00 to $74.00. On average, they predict the company's share price to reach $71.14 in the next year. This suggests a possible upside of 15.7% from the stock's current price.
View analysts price targets for REG
or view top-rated stocks among Wall Street analysts.

How have REG shares performed in 2023?

Regency Centers' stock was trading at $62.50 at the beginning of 2023. Since then, REG stock has decreased by 1.6% and is now trading at $61.47.
View the best growth stocks for 2023 here
.

When is Regency Centers' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 8th 2024.
View our REG earnings forecast
.

How were Regency Centers' earnings last quarter?

Regency Centers Co. (NASDAQ:REG) issued its earnings results on Friday, August, 4th. The company reported $0.50 EPS for the quarter, missing the consensus estimate of $1.01 by $0.51. The firm earned $314.25 million during the quarter, compared to analysts' expectations of $313.32 million. Regency Centers had a trailing twelve-month return on equity of 5.81% and a net margin of 28.97%. During the same quarter in the prior year, the firm posted $1.00 EPS.
Read the conference call transcript
.

How often does Regency Centers pay dividends? What is the dividend yield for Regency Centers?

Regency Centers declared a quarterly dividend on Thursday, November 2nd. Investors of record on Thursday, December 14th will be given a dividend of $0.67 per share on Wednesday, January 3rd. This represents a $2.68 dividend on an annualized basis and a dividend yield of 4.36%. The ex-dividend date of this dividend is Wednesday, December 13th. This is a positive change from the stock's previous quarterly dividend of $0.65.
Read our dividend analysis for REG
.

Is Regency Centers a good dividend stock?

Regency Centers (NASDAQ:REG) pays an annual dividend of $2.60 per share and currently has a dividend yield of 4.21%. REG has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 10 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 122.07%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, REG will have a dividend payout ratio of 61.61% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for REG.

How will Regency Centers' stock buyback program work?

Regency Centers announced that its Board of Directors has initiated a stock buyback plan on Thursday, February 9th 2023, which authorizes the company to repurchase $250,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 2.3% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's management believes its stock is undervalued.

Who are Regency Centers' major shareholders?

Regency Centers' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Principal Financial Group Inc. (4.29%), JPMorgan Chase & Co. (2.90%), Invesco Ltd. (2.63%), FMR LLC (2.21%), Boston Partners (2.37%) and Resolution Capital Ltd (2.02%). Insiders that own company stock include Alan Todd Roth, Dan M Chandler III, J Christian Leavitt, James D Thompson, Lisa Palmer, Martin E Stein Jr, Nicholas Andrew Wibbenmeyer and Thomas G Wattles.
View institutional ownership trends
.

How do I buy shares of Regency Centers?

Shares of REG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:REG) was last updated on 11/29/2023 by MarketBeat.com Staff

My Account -